p27kip1 deficiency confers susceptibility to gastric carcinogenesis in Helicobacter pylori-infected mice.

BACKGROUND & AIMS Determining how Helicobacter pylori promotes gastric cancer and whether H pylori eradication decreases cancer risk would be helped by suitable murine models. Mice lacking the cyclin-dependent kinase inhibitor p27kip1 are susceptible to carcinogen-induced tumors. Furthermore, p27 stimulates gastric epithelial apoptosis and inhibits proliferation, expression is decreased by H pylori, and low levels are associated with a poor prognosis in gastric cancer. We therefore evaluated p27-deficient mice as a model for H pylori-associated gastric cancer. METHODS Wild-type and p27-/- C57BL/6 mice were infected with H pylori mouse-adapted Sydney strain at 6-8 weeks of age and 6-10 mice of each type were euthanized 15, 30, 45, 60, and 75 weeks later. RESULTS Uninfected p27-/- mice developed gastric hyperplasia. H pylori-infected p27-/- mice frequently developed intestinal metaplasia (40% at 30 weeks, 67% at 45 weeks), and after 60 weeks 7 of 12 mice developed significant dysplasia and gastric cancer, recapitulating human intestinal-type gastric carcinogenesis. Wild-type mice developed intestinal metaplasia only after 75 weeks of infection; significant gastric dysplasia was observed in 1 animal (P < .05 for each comparison with p27-/- mice). No disease developed in uninfected mice. H pylori infection in p27-/- mice was associated with significantly decreased apoptosis and increased epithelial proliferation, inflammation, and H pylori density compared with infection in wild-type mice. CONCLUSIONS p27 loss and H pylori colonization cooperate to produce gastric cancer. The p27-deficient mouse affords opportunities to examine the pathogenesis of H pylori in gastric carcinogenesis and to test eradication and chemopreventive strategies.

[1]  James R. Goldenring,et al.  Gastric Cancer Originating from Bone Marrow-Derived Cells , 2004, Science.

[2]  M. Serrano,et al.  Different cooperating effect of p21 or p27 deficiency in combination with INK4a/ARF deletion in mice , 2004, Oncogene.

[3]  P. Correa,et al.  Complications of an Addisonian crisis , 2004, Gut.

[4]  E. Nabel,et al.  Bone marrow-derived immune cells regulate vascular disease through a p27(Kip1)-dependent mechanism. , 2004, The Journal of clinical investigation.

[5]  H. Eguchi,et al.  p27kip1 regulates the apoptotic response of gastric epithelial cells to Helicobacter pylori , 2004, Gut.

[6]  Tohru Natsume,et al.  Skp2-mediated degradation of p27 regulates progression into mitosis. , 2004, Developmental cell.

[7]  James M. Roberts,et al.  p27Kip1 modulates cell migration through the regulation of RhoA activation. , 2004, Genes & development.

[8]  D. Pritchard,et al.  How useful are the rodent animal models of gastric adenocarcinoma? , 2004, Alimentary pharmacology & therapeutics.

[9]  D. Liggitt,et al.  Distinct roles for p53, p27Kip1, and p21Cip1 during tumor development , 2004, Oncogene.

[10]  R. Hunt,et al.  Meta-analysis of the relationship between cagA seropositivity and gastric cancer. , 2003, Gastroenterology.

[11]  M. Mikuła,et al.  Quantitative detection for low levels of Helicobacter pylori infection in experimentally infected mice by real-time PCR. , 2003, Journal of microbiological methods.

[12]  J. Crabtree,et al.  The effect of gender on Helicobacter felis‐mediated gastritis, epithelial cell proliferation, and apoptosis in the mouse model , 2003, The Journal of pathology.

[13]  Wancai Yang,et al.  Targeted inactivation of p27kip1 is sufficient for large and small intestinal tumorigenesis in the mouse, which can be augmented by a Western-style high-risk diet. , 2003, Cancer research.

[14]  H. Eguchi,et al.  Helicobacter pylori increases proteasome-mediated degradation of p27(kip1) in gastric epithelial cells. , 2003, Cancer research.

[15]  R. Peek,et al.  Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia. , 2003, Gastroenterology.

[16]  K. Washington,et al.  Pathology of mouse models of intestinal cancer: consensus report and recommendations. , 2003, Gastroenterology.

[17]  T. Wang,et al.  Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. , 2003, Cancer research.

[18]  P. Pandolfi,et al.  p27 deficiency desensitizes Rb−/− cells to signals that trigger apoptosis during pituitary tumor development , 2003, Oncogene.

[19]  S. Suerbaum,et al.  Helicobacter pylori infection , 2013, Nature Reviews Disease Primers.

[20]  C. Belluco,et al.  Low level of p27(Kip1) protein expression in gastric adenocarcinoma is associated with disease progression and poor outcome , 2002, Journal of surgical oncology.

[21]  C. Caldas,et al.  Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. , 2002, Journal of the National Cancer Institute.

[22]  D. Graham,et al.  Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. , 2002, Gastroenterology.

[23]  M. Kaplan,et al.  The Homeostasis But Not the Differentiation of T Cells Is Regulated by p27Kip11 , 2002, The Journal of Immunology.

[24]  M. Mori,et al.  Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis. , 2002, Cancer research.

[25]  D. Liggitt,et al.  Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice. , 2002, Cancer cell.

[26]  T. Wang,et al.  Germ-line p53-targeted disruption inhibits helicobacter-induced premalignant lesions and invasive gastric carcinoma through down-regulation of Th1 proinflammatory responses. , 2002, Cancer research.

[27]  E. Hahn,et al.  Helicobacter pylori and CagA Status, Serum Gastrin, Interleukin-8 and Gastric Acid Secretion in Gastric Cancer , 2002, Scandinavian journal of gastroenterology.

[28]  M. Blaser,et al.  Helicobacter pylori and gastrointestinal tract adenocarcinomas , 2002, Nature Reviews Cancer.

[29]  S. Kawauchi,et al.  Combined examination of p27Kip1, p21Waf1/Cip1 and p53 expression allows precise estimation of prognosis in patients with gastric carcinoma , 2001, Histopathology.

[30]  L. Hansson,et al.  Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. , 2001, Gastroenterology.

[31]  P. Pharoah,et al.  Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. , 2001, Gastroenterology.

[32]  N. Sasaki,et al.  Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.

[33]  P. Malfertheiner,et al.  Effect of Helicobacter pylori eradication on expression of cyclin D2 and p27 in gastric intestinal metaplasia , 2001, Alimentary pharmacology & therapeutics.

[34]  J. Mestan,et al.  Skp2 is oncogenic and overexpressed in human cancers , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  C J Kemp,et al.  p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. , 2001, Experimental cell research.

[36]  J. Beaulieu,et al.  Role of p27(Kip1) in human intestinal cell differentiation. , 2001, Gastroenterology.

[37]  M. Kitagawa,et al.  Down-Regulation of p27Kip1 Expression Is Required for Development and Function of T Cells1 , 2001, The Journal of Immunology.

[38]  L. Ventura,et al.  P27Kip1 expression and survival in NO gastric carcinoma. , 2001, Pathology, research and practice.

[39]  A. Cittadini,et al.  Loss of p27Kip1 expression is a strong independent prognostic factor of reduced survival in N0 gastric carcinomas , 2000, Cancer.

[40]  H. Hibshoosh,et al.  Chronic Helicobacter pylori Infection Induces an Apoptosis-Resistant Phenotype Associated with Decreased Expression of p27kip1 , 2000, Infection and Immunity.

[41]  J. Jang,et al.  Loss of p16 and p27 is associated with progression of human gastric cancer. , 2000, Cancer letters.

[42]  M. Carrington,et al.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer , 2000, Nature.

[43]  P. V. van Diest,et al.  Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. , 2000, The American journal of pathology.

[44]  T. Wang,et al.  Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. , 2000, Gastroenterology.

[45]  C. Prinz,et al.  Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[46]  E. Nomura,et al.  Impact of the expression of cyclin‐dependent kinase inhibitor p27Kip1 and apoptosis in tumor cells on the overall survival of patients with non–Early stage gastric carcinoma , 1999, Cancer.

[47]  M. Chang,et al.  The loss of p27 protein has an independent prognostic significance in gastric cancer. , 1999, Anticancer research.

[48]  James M. Roberts,et al.  The murine gene p27Kip1 is haplo-insufficient for tumour suppression , 1998, Nature.

[49]  T. Fujioka,et al.  Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. , 1998, Cancer research.

[50]  H. Nagai,et al.  Helicobacter pylori infection induces gastric cancer in mongolian gerbils. , 1998, Gastroenterology.

[51]  R. Hunt,et al.  Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. , 1998, Gastroenterology.

[52]  M. Loda,et al.  Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. , 1998, Cancer research.

[53]  T. Wang,et al.  Mice lacking secretory phospholipase A2 show altered apoptosis and differentiation with Helicobacter felis infection. , 1998, Gastroenterology.

[54]  Roland M. Martin,et al.  The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. , 1998, Journal of immunological methods.

[55]  G. Cattoretti,et al.  Localization and expression of p27KIP1 in multistage colorectal carcinogenesis. , 1998, Cancer research.

[56]  S. Czinn,et al.  Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. , 1997, Gastroenterology.

[57]  K. Mimori,et al.  p27 expression and gastric carcinoma , 1997, Nature Medicine.

[58]  M. Blaser,et al.  Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. , 1997, Journal of the National Cancer Institute.

[59]  J. Ferlay,et al.  Cancer and infection: estimates of the attributable fraction in 1990. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[60]  M F Dixon,et al.  A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. , 1997, Gastroenterology.

[61]  M. Loda,et al.  Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas , 1997, Nature Medicine.

[62]  M F Dixon,et al.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.

[63]  Nobuyuki Shishido,et al.  Mice Lacking p27 Kip1 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary Tumors , 1996, Cell.

[64]  James M. Roberts,et al.  A Syndrome of Multiorgan Hyperplasia with Features of Gigantism, Tumorigenesis, and Female Sterility in p27 Kip1 -Deficient Mice , 1996, Cell.

[65]  K. Manova-Todorova,et al.  Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27 Kip1 , 1996, Cell.

[66]  P. Correa,et al.  Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.